Qbrelis
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.qbrelis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Qbrelis
Azurity Pharmaceuticals specializes in developing innovative therapeutic solutions, particularly in the cardiovascular field. Their flagship product, QBRELIS® Lisinopril Oral Liquid, is an angiotensin-converting enzyme (ACE) inhibitor designed to treat hypertension in both adult and pediatric patients aged six and older. This product aids in lowering blood pressure, thereby decreasing the risk of serious cardiovascular events like strokes and myocardial infarctions. Azurity Pharmaceuticals aims to provide effective and reliable medications while ensuring patient safety through comprehensive information and support.Explore more
Popular SearchesQbrelisAzurity Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Qbrelis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Qbrelis launches new products
Qbrelis, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Qbrelis has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Qbrelis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Qbrelis has new funding data
Congratulate Masked Content for being promoted to Masked Content at Qbrelis
Check out if Qbrelis is spiking on competitors!
Click to see if Qbrelis had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Qbrelis
Compare insights from companies similar to Qbrelis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Qbrelis
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Qbrelis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Qbrelis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Qbrelis.
Qbrelis Tech Stack
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Qbrelis
Sign Up For FreeTo access detailed company insights
Azurity Pharmaceuticals specializes in developing innovative therapeutic solutions, particularly in the cardiovascular field. Their flagship product, QBRELIS® Lisinopril Oral Liquid, is an angiotensin-converting enzyme (ACE) inhibitor designed to treat hypertension in both adult and pediatric patients aged six and older. This product aids in loweri... Read More
